Related Experiment Videos
Tracheal allograft replacement. An unsuccessful method
B Lenot1, P Macchiarini, E Dulmet
1Department of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Hôpital Marie-Lannelongue (Paris-Sud University), Plessis-Robinson, France.
Summary
This study found that allogenic grafts (AGs) for tracheal replacement failed due to necrotic tissue. None of the tested graft pretreatments (glutaraldehyde, glycerol, lyophilized, cryopreserved) proved suitable for long-segment tracheal reconstruction.
Area of Science:
- Biomedical Engineering
- Surgical Research
- Regenerative Medicine
Background:
- Tracheal conduit replacement is a significant surgical challenge.
- Developing suitable allogenic grafts (AGs) for tracheal reconstruction is crucial.
Purpose of the Study:
- To evaluate the efficacy of different allogenic graft (AG) pretreatments for cervical tracheal replacement in a porcine model.
- To identify the failure mechanisms of various AGs for long-segment tracheal reconstruction.
Main Methods:
- 20 pigs underwent cervical tracheal replacement using glutaraldehyde, glycerol, lyophilized, or cryopreserved allogenic grafts (AGs).
- No immunosuppressive agents or steroids were administered.
- Animals were monitored via weekly bronchoscopy and radiography; postmortem examination assessed graft integrity.
Main Results:
- Survival was longer for glutaraldehyde (21.6 days) and lyophilized (19.5 days) AGs compared to glycerol (6.8 days) and cryopreserved (5 days) AGs.
- Common cause of death was airway obstruction due to graft failure.
- Failure mechanisms included cartilaginous necrosis, allograft necrosis, granulation tissue, and anastomosis leakage.
Conclusions:
- Passage of necrotic tissue across the grafts was the primary failure mechanism.
- The tested allogenic graft (AG) pretreatments are unsuitable for long-segment tracheal replacement.
- Further research is needed to develop effective tracheal replacement strategies.